Compare
PMGC Holdings Inc. vs Yarrow Bioscience, Inc. vs Polomar Health Services, Inc. vs Quantum Cyber N.V.
| Latest fiscal year | PMGC Holdings Inc. ELAB | Yarrow Bioscience, Inc. YARW | Polomar Health Services, Inc. PMHS | Quantum Cyber N.V. QUCY |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $590.1K | $570.0K | $648.2K | $537.1K |
| Revenue growth (YoY) | n/a | +13.8% | n/m | -39.9% |
| Gross margin | 31.4% | n/a | 71.0% | 72.6% |
| Operating margin | n/a | n/m | n/m | n/m |
| Net margin | n/m | n/m | n/m | n/m |
| Net income | -$7.75M | -$26.48M | -$10.70M | -$16.21M |
| EPS (Diluted) | n/a | -$0.62 | -$0.39 | -$2.70 |
| Operating cash flow | -$5.93M | -$33.12M | -$396.0K | -$10.98M |
| Free cash flow | -$6.38M | -$33.12M | n/a | -$10.98M |
| Cash & equivalents | n/a | $24.03M | $132.2K | n/a |
| Total assets | $12.87M | $30.16M | $390.0K | $5.33M |
| Total liabilities | $5.03M | $2.40M | $1.61M | $4.69M |
| Shareholders' equity | $7.84M | $27.77M | -$1.22M | $641.6K |
| Return on year-end equity | -98.9% | -95.4% | n/a | n/m |
| Shares outstanding | 80.7K | 33.32M | 28.02M | 9.78M |
Revenue, most recent five fiscal years
| Fiscal year | PMGC Holdings Inc. | Yarrow Bioscience, Inc. | Polomar Health Services, Inc. | Quantum Cyber N.V. |
|---|---|---|---|---|
| Latest | $590.1K Ended 2025-12-31 | $570.0K Ended 2025-12-31 | $648.2K Ended 2025-12-31 | $537.1K Ended 2025-12-31 |
| 1 year earlier | n/a | $501.0K Ended 2024-12-31 | $58.8K Ended 2024-12-31 | $894.0K Ended 2024-12-31 |
| 2 years earlier | $1.71M Ended 2023-12-31 | $424.0K Ended 2023-12-31 | $41.8K Ended 2023-12-31 | n/a |
| 3 years earlier | $766.3K Ended 2022-12-31 | $477.0K Ended 2022-12-31 | $34.5K Ended 2022-12-31 | n/a |
| 4 years earlier | n/a | $931.0K Ended 2021-12-31 | n/a | n/a |